कृपया अन्य खोज का प्रयास करें
Initiator Pharma A/S, a clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system. Its product pipeline includes IPED2015, a drug candidate which is in clinical phase 2a for the treatment of organic erectile dysfunction; IP2018, a monoamine reuptake inhibitor which is in Phase Ib clinical trials for the treatment of psychogenic erectile dysfunction primarily targeting the serotonin followed by the dopamine system; and IPTN2021, a Phase 1 clinical drug program targeting an orphan drug indication in severe neuropathic pain, and trigeminal neuralgia. The company also developing IP2017, a proprietary triple reuptake inhibitor of 5-HT, NA, and DA; and IP2016, a preclinical development for the treatment of depression. Initiator Pharma A/S was incorporated in 2016 and is headquartered in Copenhagen, Denmark.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Gunnar Magnus Severus Modee Persson | 62 | 2016 | Chairman of the Board of Directors |
Claus Elsborg Olesen | 48 | 2016 | Co-Founder, CEO & Director |
Peter Joakim Holm | 48 | 2016 | Director |
Annette Ingegerd Colin | 57 | 2021 | Director |
Henrik Kristian Moltke | 64 | 2016 | Director |
Irwin Goldstein | - | 2020 | Member of Scientific & Clinical Advisory Board |
Sue Goldstein | - | 2020 | Member of Scientific & Clinical Advisory Board |
Gunilla Ekstrom | 64 | 2022 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है